Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.

Cell death and differentiation·2026

Same author

Spermidine enhances macrophages anti-inflammatory and regenerative functions by improving mitochondrial fitness.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2025

Same author

Multi-omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine.

Molecular oncology·2025

Same author

Unveiling the molecular profile of a prostate carcinoma: implications for personalized medicine.

Biology direct·2024

Same author

Thioredoxin-interacting protein (TXNIP) is a substrate of the NEDD4-like E3 ubiquitin-protein ligase WWP1 in cellular redox state regulation of acute myeloid leukemia cells.

Molecular oncology·2024

Same author

Molecular profiling of a bladder cancer with very high tumour mutational burden.

Cell death discovery·2024

Same journal

Retraction: Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression.

Oncotarget·2026

Same journal

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer.

Oncotarget·2026

Same journal

Retraction: MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.

Oncotarget·2026

Same journal

Laryngeal leiomyosarcoma: A rare case report and literature review.

Oncotarget·2026

Same journal

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Oncotarget·2026

Same journal

DHHC3 interferes with antitumor immunity in melanoma cells.

Oncotarget·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 1, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

miR-34: from bench to bedside.

Massimiliano Agostini¹, Richard A Knight

¹Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK.

|March 25, 2014

Summary

This summary is machine-generated.

The miR-34 family acts as a master tumor suppressor by targeting oncogenes, inhibiting cancer growth, and metastasis. miR-34a mimics are being explored for cancer therapy.

More Related Videos

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Published on: February 11, 2014

Related Experiment Videos

Last Updated: May 1, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

Published on: February 11, 2014

Area of Science:

Molecular Biology
Oncology
Genetics

Background:

The miR-34 family, identified as p53 target genes in 2007, are key regulators of tumor suppression.
Dysregulation of miR-34 expression is observed in numerous human cancers, highlighting its clinical relevance.

Purpose of the Study:

To review the miR-34 family's role in tumor biology.
To discuss the therapeutic potential of miR-34a mimics in cancer treatment.

Main Methods:

Literature review of studies on miR-34 family function and cancer.
Analysis of miR-34a mimic clinical trial data.

Main Results:

Overexpression of miR-34 family members represses oncogenes, leading to cancer cell death and reduced metastasis.
miR-34a mimics have shown promise, with one reaching Phase 1 clinical trials in 2013.

Conclusions:

The miR-34 family is a critical tumor suppressor pathway with significant implications in cancer.
miR-34a mimics represent a promising therapeutic strategy for various human cancers.